Evaluation of inhibin A concentration in maternal serum between 13 and 17 weeks of gestation.
スポンサーリンク
概要
- 論文の詳細を見る
Inhibin is produced by the syncytiotrophoblast of human placenta during pregnancy and is composed of one a -subunit and one of two related 13 -subunits (inhibin A: a - /3 A or inhibin B: a l3 B). Several foreign studies have shown that maternal serum inhibin A levels are raised on average in second trimester pregnancies affected with Down's syndrome. The purpose of this study was to investigate dimeric inhibin A concentration in the second trimester for normal Japanese pregnancies. Additionally we examined the distribution of inhibin A concentration in Down's syndrome pregnancies. The results indicated almost no variation of the median value across the 146 to 16th week of pregnancy. As negative correlation was observed between concentration of inhibin A and maternal weight, the median MoM should be corrected by the weight of each pregnant woman. Significant correlation was observed between inhibin A and hCG concentration. The increase in the serum concentration of inhibin A from women with affected by Down's syndrome was observed, although the number of pregnancies affected was limited. [Adv Obstet Gynecol 52 (1); 6 13, 2000 (H.12.1)]
- 近畿産科婦人科学会の論文
近畿産科婦人科学会 | 論文
- 当院における卵巣粘液性腺癌の治療経験の検討
- 婦人科癌末期の難治性イレウスに対する減圧目的の経皮的内視鏡的胃瘻造設について
- 子宮体癌の保存的治療後妊娠での前置癒着胎盤に対し内腸骨動脈バルーン留置下で帝王切開および子宮全摘術を施行した1例
- 当科の卵巣粘液性腺癌の治療成績 : ─リンパ節郭清の適応についての考察
- 妊娠糖尿病を合併した高度肥満妊婦の分娩誘発の1例